These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38940325)

  • 1. Ocular Manifestations of Fabry Disease: Report from a Tertiary Eye Care Center in Türkiye.
    Korkmaz İ; Kalkan Uçar S; Onay H; Yıldırım Sözmen E; Çoker M; Palamar M
    Turk J Ophthalmol; 2024 Jun; 54(3):127-132. PubMed ID: 38940325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre.
    Nguyen TT; Gin T; Nicholls K; Low M; Galanos J; Crawford A
    Clin Exp Ophthalmol; 2005 Apr; 33(2):164-8. PubMed ID: 15807825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients.
    Orssaud C; Dufier J; Germain D
    Ophthalmic Genet; 2003 Sep; 24(3):129-39. PubMed ID: 12868031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of ocular involvement in patients with Fabry disease.
    Wu Y; Zhang W; Yao X; Song W; Zhao Y; Yuan Y; Zhang W
    Ann Med; 2023 Dec; 55(1):2226909. PubMed ID: 37354009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual outcome, ocular findings, and visual quality of life in patients with Fabry disease.
    Nilsson M; Kolagari HT; Epstein D; Samolov B; Olsson M; Naess K; Oscarson M; Teaer Fahnehjelm K
    Ophthalmic Genet; 2022 Dec; 43(6):841-849. PubMed ID: 36325813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey.
    Sodi A; Ioannidis AS; Mehta A; Davey C; Beck M; Pitz S
    Br J Ophthalmol; 2007 Feb; 91(2):210-4. PubMed ID: 16973664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabry disease and chemosis.
    Edwards JD; Bower KS; Brooks DB; Walter A
    Cornea; 2009 Feb; 28(2):224-7. PubMed ID: 19158572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctival lymphangiectasia associated with classic Fabry disease.
    Sivley MD; Wallace EL; Warnock DG; Benjamin WJ
    Br J Ophthalmol; 2018 Jan; 102(1):54-58. PubMed ID: 28500230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ophthalmic manifestations in Mexican patients with Fabry disease].
    Beltrán-Becerra KJ; Ríos-González BE; Gutiérrez-Amavizca BE; Silva-Noriega DA; Figuera LE
    Arch Soc Esp Oftalmol; 2012 Nov; 87(11):373-5. PubMed ID: 23058197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal densitometry: a potential indicator for early diagnosis of Fabry disease.
    Li S; Siggel R; Guo Y; Loreck N; Rokohl AC; Kurschat C; Heindl LM
    Graefes Arch Clin Exp Ophthalmol; 2021 Apr; 259(4):941-948. PubMed ID: 33258999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal and conjunctival manifestations in Fabry disease: in vivo confocal microscopy study.
    Mastropasqua L; Nubile M; Lanzini M; Carpineto P; Toto L; Ciancaglini M
    Am J Ophthalmol; 2006 Apr; 141(4):709-18. PubMed ID: 16564807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study on ocular manifestations in a cohort of patients with Fabry disease.
    Michaud L
    PLoS One; 2019; 14(6):e0213329. PubMed ID: 31246960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular findings and their correlation with disease severity in Fabry disease in South-East Anatolia.
    Mete A; Dogan L; Ozcakmakci GB; Sayiner ZA; Gungor K
    Int Ophthalmol; 2023 Jul; 43(7):2301-2306. PubMed ID: 36595126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer assisted evaluation of retinal vessels tortuosity in Fabry disease.
    Sodi A; Guarducci M; Vauthier L; Ioannidis AS; Pitz S; Abbruzzese G; Sofi F; Mecocci A; Miele A; Menchini U
    Acta Ophthalmol; 2013 Mar; 91(2):e113-9. PubMed ID: 23164241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ocular manifestations in Fabry's disease.
    Sher NA; Letson RD; Desnick RJ
    Arch Ophthalmol; 1979 Apr; 97(4):671-6. PubMed ID: 106811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy-lysosome pathway alteration in ocular surface manifestations in Fabry disease patients.
    Marenco M; Segatto M; Sacchetti M; Mangiantini P; Giovannetti F; Plateroti R
    Orphanet J Rare Dis; 2022 Jul; 17(1):291. PubMed ID: 35870972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmic experience over 10 years in an observational nationwide Danish cohort of Fabry patients with access to enzyme replacement.
    Fledelius HC; Sandfeld L; Rasmussen ÅK; Madsen CV; Feldt-Rasmussen U
    Acta Ophthalmol; 2015 May; 93(3):258-64. PubMed ID: 25487570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular signs correlate well with disease severity and genotype in Fabry disease.
    Pitz S; Kalkum G; Arash L; Karabul N; Sodi A; Larroque S; Beck M; Gal A
    PLoS One; 2015; 10(3):e0120814. PubMed ID: 25781336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cornea verticillata in Fabry disease: a comparative study between slit-lamp examination and in vivo corneal confocal microscopy.
    Leonardi A; Carraro G; Modugno RL; Rossomando V; Scalora T; Lazzarini D; Calò L
    Br J Ophthalmol; 2020 May; 104(5):718-722. PubMed ID: 31401555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of corneal topographic, tomographic, densitometric, and biomechanical properties of Fabry patients with ocular manifestations.
    Cankurtaran V; Tekin K; Cakmak AI; Inanc M; Turgut FH
    Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1057-1064. PubMed ID: 31915973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.